» Articles » PMID: 31927662

Assessing the Health Impact of Interventions for Baker's Allergy and Asthma in Supermarket Bakeries: a Group Randomised Trial

Overview
Date 2020 Jan 14
PMID 31927662
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To assess the impact of an intervention for baker's allergy and asthma in supermarket bakeries.

Methods: A group randomised trial conducted in 31 bakeries (n = 337 bakers) that were randomly assigned to one of two intervention groups (n = 244 bakers) and a control group (n = 93 bakers). Health data collected prior to and 1-year after the intervention included information obtained from an ECRHS questionnaire; tests for atopy and serum-specific IgE to cereal flours; fractional exhaled nitric oxide (FeNO). Data from the two intervention groups were combined to form one intervention group for purposes of the statistical analysis.

Results: At 1 year of follow-up, the incidence and level of decline of work-related ocular-nasal and chest symptoms, sensitisation status and elevated FeNO (FeNO > 25 ppb) was similar in both intervention and control groups. The mean FeNO difference was also similar across both groups (2.2 ppb vs 1.7 ppb, p = 0.86). In those with FeNO > 25 ppb at baseline, the decline was greater in the intervention compared to control group (16.9 ppb vs 7.7 ppb, p = 0.24). Multivariate logistic regression models (adjusting for smoking, baseline sensitisation to cereal flour, baseline FeNO > 25 ppb) did not demonstrate an appreciable FeNO decline (≥ 10%) in the intervention compared to control group. However, stratification by the presence of work-related ocular-nasal symptoms in bakers at baseline demonstrated a significant FeNO decline (≥ 10%) in the intervention compared to the control group (OR 3.73, CI 1.22-11.42).

Conclusion: This study demonstrates some evidence of an intervention effect on FeNO 1 year after an intervention, particularly in bakers with work-related ocular-nasal symptoms.

Citing Articles

A cross-sectional analysis of medical conditions and environmental factors associated with fractional exhaled nitric oxide (FeNO) in women and children from the ISA birth cohort, Costa Rica.

Werthmann D, van Wendel de Joode B, Cuffney M, Reich B, Soto-Martinez M, Corrales-Vargas A Environ Res. 2023; 233:116449.

PMID: 37356534 PMC: 10529647. DOI: 10.1016/j.envres.2023.116449.


The value of fractional exhaled nitric oxide in occupational diseases - a systematic review.

Otelea M, Fell A, Handra C, Holm M, Larese Filon F, Mijakovski D J Occup Med Toxicol. 2022; 17(1):14.

PMID: 35879723 PMC: 9317127. DOI: 10.1186/s12995-022-00355-1.


From Polyclonal Sera to Recombinant Antibodies: A Review of Immunological Detection of Gluten in Foodstuff.

Garcia-Calvo E, Garcia-Garcia A, Madrid R, Martin R, Garcia T Foods. 2021; 10(1).

PMID: 33396828 PMC: 7824297. DOI: 10.3390/foods10010066.


Occupational asthma and rhinitis due to wheat flour: sublingual specific immunotherapy treatment.

Dubini M, Marraccini P, Brass D, Patrini L, Riboldi L Med Lav. 2020; 111(3):203-209.

PMID: 32624562 PMC: 7809951. DOI: 10.23749/mdl.v111i3.9446.

References
1.
Boulay M, Morin A, Laprise C, Boulet L . Asthma and rhinitis: what is the relationship?. Curr Opin Allergy Clin Immunol. 2012; 12(5):449-54. DOI: 10.1097/ACI.0b013e328357cc32. View

2.
Rolla G, Guida G, Heffler E, Badiu I, Bommarito L, De Stefani A . Diagnostic classification of persistent rhinitis and its relationship to exhaled nitric oxide and asthma: a clinical study of a consecutive series of patients. Chest. 2007; 131(5):1345-52. DOI: 10.1378/chest.06-2618. View

3.
Jolly A, Klees J, Pacheco K, Guidotti T, Kipen H, Biggs J . Work-Related Asthma. J Occup Environ Med. 2015; 57(10):e121-9. DOI: 10.1097/JOM.0000000000000572. View

4.
Baatjies R, Meijster T, Heederik D, Sander I, Jeebhay M . Effectiveness of interventions to reduce flour dust exposures in supermarket bakeries in South Africa. Occup Environ Med. 2014; 71(12):811-8. DOI: 10.1136/oemed-2013-101971. View

5.
Piirila P, Nordman H, Keskinen H, Luukkonen R, Salo S, Tuomi T . Long-term follow-up of hexamethylene diisocyanate-, diphenylmethane diisocyanate-, and toluene diisocyanate-induced asthma. Am J Respir Crit Care Med. 2000; 162(2 Pt 1):516-22. DOI: 10.1164/ajrccm.162.2.9909026. View